Mechanistic insight of SARS-CoV-2 infection using human hepatobiliary organoids

Yi Zhao,Xiaoxue Ren,Jing Lu,Minghui He,Zhe Liu,Lina Yi,Mingle Huang,Ming Kuang,Haipeng Xiao,Joseph JY Sung,Xiaoxing Li,Lixia Xu,Jun Yu
DOI: https://doi.org/10.1136/gutjnl-2021-326617
IF: 24.5
2022-12-08
Gut
Abstract:We have read with interest in a recent study published in Gut by Weber et al ,1 reporting abnormal elevation of gamma-glutamyltransferase (37%) and total bilirubin (5%) in patients, that was associated with higher rates of COVID-19-related deaths. However, whether SARS-CoV-2 could infect human hepatocytes and cholangiocytes thus causing local damage has not been reported. Here, human organoids were used to investigate SARS-CoV-2 infection and its induced liver damage at cellular and molecular levels (figure 1A). We first established five lines of liver organoids and two lines of biliary organoids from adjacent normal tissues of seven patients with liver cancer (figure 1B; ; ). We examined the susceptibility of human liver and biliary organoids to SARS-CoV-2 (Guangdong/20SF014/2020; EPI_ISL_403934; 19A) directly isolated from a patient with moderate COVID-19. The expression of SARS-CoV-2 spike (S) glycoprotein protein was readily detected in patchy areas of human liver...
gastroenterology & hepatology
What problem does this paper attempt to address?